Recruiting

Middle Meningeal Arteryembolization

Sponsor:

Methodist Health System

Code:

NCT07490197

Conditions

Trauma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Medical/Phenotype Data Collection Procedures & Data to be Collected

Study Details

Brief summary:

This retrospective data repository will serve as a means to aggregate and analyze standard surgical interventions and Middle Meningeal Arteryembolization as suitable treatment options for Acute Subdural Hematoma.

Conditions

Trauma

Study ID

NCT07490197

Start date

Jan 30, 2024

Status verified date

Feb, 2026

Completion date

Feb, 2028

Anticipated

Primary completion date

Feb, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • ≥18 years old
  • Included in the Methodist Dallas Medical Center Trauma Registry
  • Acute subdural hematoma identified on computed tomography scan or magnetic resonance imaging of the brain in the trauma bay within 72 hours of a traumatic event

Exclusion Criteria:

  • <18 years old
  • Prisoners, pregnant persons, or other protected population

Study Design

Enrollment

100 participants

Anticipated

Interventions and Outcome Measures

Arms

Total Number and Description of Study Sites/Total Number of Subjects

This study will include all trauma patients who meet registry inclusion and arrive at the Methodist Dallas Medical Center trauma bay with Acute subdural hematoma . Enrollment will terminate once adequate number of interventions have been observed for clinical significance to be established.

Interventions

Medical/Phenotype Data Collection Procedures & Data to be Collected

TheMethodist Dallas Medical Center Trauma Registry will be queried for demographic information, diagnosis codes, admission dates, traumatic injury characteristics, surgical procedures, comorbidities, inpatient outcomes, complications, consultations, discharge location, and mortality. Additional laboratory values will be abstracted from Epic through retrospective chart review.

Primary outcome measure

  • Total Number of Study Sites [ Time Frame: 5 years ]

Central Contacts and Locations

Central contacts

Crystee Cooper, DHEd

214-947-1280ClinicalResearch@mhd.com

Kavya Mankulangara

214-947-4604ClinicalResearch@mhd.com

Locations

Methodist Dallas Medical Center- Clinical Research Institute

Recruiting

Dallas, Texas, United States, 75203

Contacts

Colette Ngo Ndjom

214-947-1289ClinicalResearch@mhd.com

Kavya Mankulangara

214-947-4604ClinicalResearch@mhd.com

More Information

Sponsor

Methodist Health System

Last update posted

Aug 4, 2026

Last verified

Feb, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Methodist Health System on 2026-08-04.